The U.S. government is committing millions of dollars in support for leading Ebola vaccine programs at Merck and Johnson & Johnson.

Bavarian Nordic has secured a U.S. smallpox vaccine stockpiling contract potentially worth $539 million.

Here's some other vaccine news of note for this week.

Serum Institute of India has new results from a phase 3 trial of its rotavirus vaccine as it preps to deliver millions of doses.

After a major cancer vaccine misstep, Bavarian Nordic reported positive six-week data from an ongoing phase 2 study on its RSV vaccine candidate.

Inovio and GeneOne have started a clinical study of their MERS vaccine in South Korea, where the virus took 36 lives in a 2015 outbreak.

Here's some other vaccine news of note for this week.

Johnson & Johnson and a U.S. development agency are zeroing in on pandemic flu in a novel deal focusing on vaccine and flu drug candidates.